News and Announcements
Actinogen Medical’s Understanding Alzheimer’s Event
- Published September 19, 2016 1:46PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Actinogen Medical looks forward to seeing you at our “Understanding Alzheimer’s” Symposium in Melbourne this Wednesday! Don’t forget to RSVP to reserve your spot, if you haven’t done so already – we’re sure it will be a meaningful event.
The Brains Behind Saving Yours
Alzheimer’s disease is one of the greatest health issues of our time. Join us on World Alzheimer’s Day to hear from leading experts in Alzheimer’s research and individuals experienced in coping with the burden of the disease. They will be discussing all aspects of Alzheimer’s including the progress being made in developing effective treatments for this devastating condition.
Speakers
Dr. Bill Ketelbey CEO & Managing Director,Actinogen Medical
Anne Fairhall Carer Advocate, Alzheimer’s Australia Vic
Professor Colin Masters The Florey Institute & University of Melbourne Professor
Ralph Martins McCusker Foundation & Edith Cowan University
Event Details
Novotel Melbourne, 270 Collins Street 5:30pm – 7:30pm Wednesday, 21 September, 2016
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
